285 related articles for article (PubMed ID: 12676867)
21. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.
Kobayashi H
Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Lee B; Haagensen JA; Ciofu O; Andersen JB; Høiby N; Molin S
J Clin Microbiol; 2005 Oct; 43(10):5247-55. PubMed ID: 16207991
[TBL] [Abstract][Full Text] [Related]
23. Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis.
Häussler S; Tümmler B; Weissbrodt H; Rohde M; Steinmetz I
Clin Infect Dis; 1999 Sep; 29(3):621-5. PubMed ID: 10530458
[TBL] [Abstract][Full Text] [Related]
24. Secondary messenger signalling influences Pseudomonas aeruginosa adaptation to sinus and lung environments.
Ruhluel D; Fisher L; Barton TE; Leighton H; Kumar S; Amores Morillo P; O'Brien S; Fothergill JL; Neill DR
ISME J; 2024 Jan; 18(1):. PubMed ID: 38647527
[TBL] [Abstract][Full Text] [Related]
25. Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.
Jensen PØ; Kolpen M; Kragh KN; Kühl M
APMIS; 2017 Apr; 125(4):276-288. PubMed ID: 28407427
[TBL] [Abstract][Full Text] [Related]
26. Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs.
Malone JG
Infect Drug Resist; 2015; 8():237-47. PubMed ID: 26251621
[TBL] [Abstract][Full Text] [Related]
27. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
28. Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites.
Bielecki P; Komor U; Bielecka A; Müsken M; Puchałka J; Pletz MW; Ballmann M; Martins dos Santos VA; Weiss S; Häussler S
Environ Microbiol; 2013 Feb; 15(2):570-87. PubMed ID: 23145907
[TBL] [Abstract][Full Text] [Related]
29. Otopathogenic Pseudomonas aeruginosa strains as competent biofilm formers.
Wang EW; Jung JY; Pashia ME; Nason R; Scholnick S; Chole RA
Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):983-9. PubMed ID: 16301370
[TBL] [Abstract][Full Text] [Related]
30. Pseudomonas aeruginosa biofilms in cystic fibrosis.
Høiby N; Ciofu O; Bjarnsholt T
Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
[TBL] [Abstract][Full Text] [Related]
31. Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model.
Rodríguez-Sevilla G; García-Coca M; Romera-García D; Aguilera-Correa JJ; Mahíllo-Fernández I; Esteban J; Pérez-Jorge C
Int J Med Microbiol; 2018 Apr; 308(3):413-423. PubMed ID: 29555180
[TBL] [Abstract][Full Text] [Related]
32. Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis.
Ferreira AG; Leão RS; Carvalho-Assef AP; Folescu TW; Barth AL; Marques EA
APMIS; 2010 Aug; 118(8):606-12. PubMed ID: 20666742
[TBL] [Abstract][Full Text] [Related]
33. Characterization of colony morphology variants isolated from Pseudomonas aeruginosa biofilms.
Kirisits MJ; Prost L; Starkey M; Parsek MR
Appl Environ Microbiol; 2005 Aug; 71(8):4809-21. PubMed ID: 16085879
[TBL] [Abstract][Full Text] [Related]
34. Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections.
Ciofu O; Mandsberg LF; Wang H; Høiby N
FEMS Immunol Med Microbiol; 2012 Jul; 65(2):215-25. PubMed ID: 22540844
[TBL] [Abstract][Full Text] [Related]
35. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
Hogardt M; Heesemann J
Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
[TBL] [Abstract][Full Text] [Related]
36. Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or "Old Hat"?
Su S; Hassett DJ
Expert Opin Ther Targets; 2012 Sep; 16(9):859-73. PubMed ID: 22793158
[TBL] [Abstract][Full Text] [Related]
37. Pseudomonas aeruginosa Strains from Both Clinical and Environmental Origins Readily Adopt a Stable Small-Colony-Variant Phenotype Resulting from Single Mutations in c-di-GMP Pathways.
Besse A; Groleau MC; Trottier M; Vincent AT; Déziel E
J Bacteriol; 2022 Oct; 204(10):e0018522. PubMed ID: 36102640
[TBL] [Abstract][Full Text] [Related]
38. P. aeruginosa Biofilms in CF Infection.
Wagner VE; Iglewski BH
Clin Rev Allergy Immunol; 2008 Dec; 35(3):124-34. PubMed ID: 18509765
[TBL] [Abstract][Full Text] [Related]
39. An ex vivo lung model to study bronchioles infected with Pseudomonas aeruginosa biofilms.
Harrison F; Diggle SP
Microbiology (Reading); 2016 Oct; 162(10):1755-1760. PubMed ID: 27520088
[TBL] [Abstract][Full Text] [Related]
40. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection.
Costerton JW
Trends Microbiol; 2001 Feb; 9(2):50-2. PubMed ID: 11173226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
